1Fulop M. Alcoholic ketoacidosis. Endocrinol Metab Clin N Am, 1993, 22:209-219.
2Halperin ML, Hammeke M, Josse RG, et al. Metabolic acidosis in the alcoholic: A pathophysiologic approach. Metabolism, 1983, 32: 308 -315.
3Adrogue HJ, Wilson H, Boyd AE, et al. Plasma acid-base patterns in diabetic ketoacidosis. N Engl J Med,1982, 307:1603 - 1610.
4Umpierrez GE, DiGirolamo M, Tuvlin JA, et al. Differences in metabolic and hormonal milieu in diabetic and alcohol-induced ketoacidosis. J Crit Care, 2000, 15:52 -59.
5Woolf AD. The Haitian diethylene glycol poisoning tragedy: A dark wood revisited. JAMA,1998, 279:1215-1216.
9Barnes B J, Gerst C, Smith JR, et al. Osmol gap as a surrogate marker for serum propylene glycol concentrations in patients receiving lorazepam for sedation. Pharmacotherapy, 2006, 26 : 23 - 33.
10Zar T, Graeber C, Perazella MA. Recognition, treatment, and prevention of propylene glycol toxicity. Semin Dial, 2007, 20:217 -219.
4]ietruszko R, Voigtlander K, Lester D. Alcohol dehydrogenase fi'om human and horse liver-substrate specificity with diols [J]. Biochem Pharmaeol, 1978, 27(8): 1296-1297.
5Burns MJ, Graudins A, Aaron CK, et al. Treatment of methanol poi- soning with intravenous 4-methypyrazole [J]. Ann Emerg Med, 1997, 30(6): 829-832.
6Mc Stay CM, Gordon PE. Images in clinical medicine. Urine fluo- rescence in ethylene glycol poisoning [J]. N EnglJ Med, 2007, 356 (6): 611.
7Barceloux DG, Krenzelok EP, Olson K, et al. American academy of clinical toxicology practice guidelines on the treatment of ethylene. glycol poisoning [J]. J Toxicol Clin Toxicol, 1999, 37(5): 537-560.
8Schauben J. Methanol and ethylene glycol toxicity [J]. US Pharma- cist, 1998, 23(Suppl): 22-33.
9Henderson WR, Brubacher J. Methanol and ethylene glycol poison- ing: a case study and review of current literature [J]. CJEM, 2002, 4 (1): 34-40.
